We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Procter & Gamble (P&G) Pharmaceuticals and ARYx Therapeutics, a private drug discovery and development company, have announced a strategic alliance under which P&G will develop and commercialize ARYx's drug ATI-7505 for the treatment of gastrointestinal (GI) disorders such as gastroesophageal reflux disease (GERD) and gastroparesis.
Bayer has announced that its acquisition of German drugmaker Schering AG has been completed, with it now holding 92.4 percent of the company's 191 million shares.
Japanese drugmaker Eisai and Teva Pharmaceutical announced that they have mutually agreed to end their May 2003 alliance to co-promote Teva's Azilect (rasagiline tablets) for Parkinson's disease in the U.S.
A new pain drug based on the venom of a deadly sea snail was launched in Britain on Monday, offering hope to patients with chronic pain who do not respond to or cannot tolerate treatments like morphine.
Serono has announced that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) of Rebif (interferon beta-1a), in order to align it with current medical practice.
Futura Medical plc, the pharmaceutical drug and medical device group that develops innovative products for sexual health, announced that it has entered into a development agreement with GlaxoSmithKline Consumer Healthcare (GSK-CH) for Futura's topically applied gel (MED2002) for the treatment of erectile dysfunction (ED).
Parexel International Corporation, a biopharmaceutical outsourcing organizations, has entered into a joint venture (JV) arrangement with Synchron Research Services Private Limited, pursuant to which it purchased a majority stake in a newly formed entity called Parexel International Synchron Private Limited into which Synchron transferred its clinical trial business operations located in Bangalore, India.
Danish pharmaceutical company H. Lundbeck A/S (LUN.KO) Tuesday said that it has, together with Forest Laboratories, Inc. (FRX) and Forest Laboratories Holdings Ltd. filed a lawsuit in the U.S. District Court for the Eastern District of Michigan against Caraco Pharmaceutical Laboratories, Ltd.